|
|
Volumn 2, Issue 3, 2001, Pages 123-130
|
|
IGF-I treatment of diabetes
|
|
Author keywords
Growth hormone; IGFBP 1; IGFBP 3; Insulin; Retinopathy; Type 1 diabetes
|
|
Indexed keywords
GLUCOSE;
GROWTH HORMONE;
INSULIN;
PLACEBO;
PROTEIN;
RECOMBINANT SOMATOMEDIN C;
SODIUM CHLORIDE;
SOMATOMEDIN B;
SOMATOMEDIN BINDING PROTEIN 1;
SOMATOMEDIN BINDING PROTEIN 3;
SOMATOMEDIN C;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BELL PALSY;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG SAFETY;
EDEMA;
FEMALE;
GLUCOSE BLOOD LEVEL;
GLUCOSE METABOLISM;
HEADACHE;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
MALE;
MULTICENTER STUDY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PAIN;
PRIORITY JOURNAL;
PROTEIN METABOLISM;
RANDOMIZED CONTROLLED TRIAL;
RETINOPATHY;
|
|
EID: 0034902114
PISSN: 1399543X
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1399-5448.2001.002003123.x Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
